ANI PHARMACEUTICALS INC financial data

Symbol
ANIP on Nasdaq
Location
Baudette, MN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 262% % -19%
Quick Ratio 57% % -28%
Debt-to-equity 186% % 23%
Return On Equity 16% %
Return On Assets 5.7% %

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 22,491,281 shares 6.6%
Entity Public Float $1,300,000,000 USD 8.3%
Common Stock, Value, Issued $3,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 20,053,000 shares 3.8%
Weighted Average Number of Shares Outstanding, Diluted 21,228,000 shares 9.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $883,366,000 USD 44%
Research and Development Expense $51,664,000 USD 16%
Costs and Expenses $772,273,000 USD 26%
Operating Income (Loss) $111,093,000 USD 18923%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $95,791,000 USD
Income Tax Expense (Benefit) $17,454,000 USD
Net Income (Loss) Attributable to Parent $78,337,000 USD
Earnings Per Share, Basic 3.5 USD/shares
Earnings Per Share, Diluted 3.32 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $285,585,000 USD 97%
Accounts Receivable, after Allowance for Credit Loss, Current $281,082,000 USD 27%
Inventory, Net $143,067,000 USD 4.6%
Assets, Current $753,117,000 USD 43%
Deferred Income Tax Assets, Net $69,072,000 USD -19%
Property, Plant and Equipment, Net $62,476,000 USD 9.9%
Operating Lease, Right-of-Use Asset $5,200,000 USD
Intangible Assets, Net (Excluding Goodwill) $479,526,000 USD -11%
Goodwill $62,480,000 USD 4.2%
Other Assets, Noncurrent $13,706,000 USD 12%
Assets $1,440,377,000 USD 12%
Accounts Payable, Current $62,583,000 USD 37%
Employee-related Liabilities, Current $37,897,000 USD 0.46%
Accrued Liabilities, Current $16,803,000 USD 22%
Contract with Customer, Liability, Current $5,000,000 USD
Liabilities, Current $278,112,000 USD 43%
Operating Lease, Liability, Noncurrent $9,173,000 USD 109%
Other Liabilities, Noncurrent $12,164,000 USD 110%
Liabilities $899,653,000 USD 5.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,033,000 USD -81%
Retained Earnings (Accumulated Deficit) $23,099,000 USD 77%
Stockholders' Equity Attributable to Parent $540,724,000 USD 34%
Liabilities and Equity $1,440,377,000 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $34,991,000 USD 92%
Net Cash Provided by (Used in) Financing Activities $9,906,000 USD 50%
Net Cash Provided by (Used in) Investing Activities $19,846,000 USD -322%
Common Stock, Shares Authorized 66,000,000 shares 98%
Common Stock, Shares, Issued 23,112,577 shares 7.3%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,942,000 USD -34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $285,621,000 USD 97%
Interest Paid, Excluding Capitalized Interest, Operating Activities $8,895,000 USD 12%
Deferred Tax Assets, Valuation Allowance $12,423,000 USD 31%
Deferred Tax Assets, Gross $104,032,000 USD -14%
Operating Lease, Liability $11,096,000 USD 79%
Payments to Acquire Property, Plant, and Equipment $2,474,000 USD -46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $74,026,000 USD
Lessee, Operating Lease, Liability, to be Paid $14,272,000 USD 98%
Operating Lease, Liability, Current $1,923,000 USD 6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,835,000 USD 59%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,597,000 USD 25%
Operating Lease, Weighted Average Discount Rate, Percent 0.0774 pure -4.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,176,000 USD 211%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,147,000 USD 20%
Deferred Tax Assets, Operating Loss Carryforwards $28,148,000 USD 3.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,666,667 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,679,000 USD 64%
Additional Paid in Capital $596,036,000 USD 15%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $82,500,000 USD 37%
Deferred Tax Assets, Net of Valuation Allowance $91,609,000 USD -18%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%